Brokerages have given Selecta Biosciences, Inc. (NASDAQ:SELB) a consensus rating of “Buy.”
According to Bloomberg.com, the seven rating agencies currently monitoring the stock have given the stock of Selecta Biosciences, INC (NASDAQ: ...
Tag: SELB, Analyst Rating
Mangrove Partners Reduces Its Investment in Selecta Biosciences, Inc.
The most recent 13F filing that Mangrove Partners submitted with the SEC revealed that during the third quarter, the investment ...
The Healthcare of Ontario Pension Plan Trust Fund has invested $1.18 million in Selecta Biosciences, Inc. (NASDAQ:SELB)
According to the most recent Form 13F filing that the Healthcare of Ontario Pension Plan Trust Fund made with the ...
Selecta Biosciences (SELB) will report third-quarter earnings on Thursday.
On Thursday, March 2, before the opening of the market, Selecta Biosciences, INC (NASDAQ: SELB) will release its quarterly earnings ...